Showing results (281-290 of 302) with videos related to

Sort By:
Pageof 31
Neuro-Oncology|April 5, 2022
Hypothetical generalized framework for a new imaging endpoint of therapeutic activity in early phase clinical trials in brain tumorsBenjamin M Ellingson, Elizabeth R Gerstner, Andrew B Lassman, et al.
British Journal of Haematology|August 7, 2024
Single gene mutations and prognosis in limited-stage follicular lymphoma treated with radiation therapySamantha A Hershenfeld, Josuha W D Tobin, Victoria Shelton, et al.
American Journal of Hematology|September 10, 2022
Clinical significance of clonal hematopoiesis in the setting of autologous stem cell transplantation for lymphomaTracy Lackraj, Sharon Ben Barouch, Jessie J F Medeiros, et al.
JBMR Plus|October 27, 2025
Medical guidelines for fibrodysplasia ossificans progressivaFrederick S Kaplan, Mona Al Mukaddam, Genevieve Baujat, et al.
Research Square|July 25, 2025
Multi-omic insights from a multi-ancestry genome-wide meta-analysis of ankylosing spondylitis reveal novel pathways of disease susceptibilityMatthew Brown, Zhixiu Li, Xin Wu, et al.
The Journal of Allergy and Clinical Immunology|February 26, 2018
Loss-of-function nuclear factor κB subunit 1 (NFKB1) variants are the most common monogenic cause of common variable immunodeficiency in EuropeansPaul Tuijnenburg, Hana Lango Allen, Siobhan O Burns, et al.
Frontiers in Public Health|April 28, 2025
Public health diplomacy: summary of the methods and outcome of the 1st University of Memphis School of Public Health Diplomacy SummitAshish Joshi, Laura Magana, Kun-Hsien Tsai, et al.
Biorxiv : the Preprint Server for Biology|November 1, 2024
T cell epitope mapping reveals immunodominance of evolutionarily conserved regions within SARS-CoV-2 proteomeCansu Cimen Bozkus, Matthew Brown, Leandra Velazquez, et al.
Iscience|August 1, 2025
T cell epitope mapping reveals immunodominance of evolutionarily conserved regions within SARS-CoV-2 proteomeCansu Cimen Bozkus, Matthew Brown, Leandra Velazquez, et al.
Journal of Medicinal Chemistry|December 4, 2014
Discovery and in vivo evaluation of (S)-N-(1-(7-fluoro-2-(pyridin-2-yl)quinolin-3-yl)ethyl)-9H-purin-6-amine (AMG319) and related PI3Kδ inhibitors for inflammation and autoimmune diseaseTimothy D Cushing, Xiaolin Hao, Youngsook Shin, et al.
Pageof 31